期刊文献+

右美托咪定在神经重症监护室颅脑外伤躁动患者镇静中的应用 被引量:18

暂未订购
导出
摘要 目的探讨右美托咪定对颅脑外伤躁动患者镇静的有效性及安全性。方法选取28例颅脑外伤躁动患者,给予右美托咪定首剂1μg/kg的负荷量于10 min静推完毕,之后给予0.2~0.7μg.kg-1.h-1的维持量,镇静目标为Ramsay评分2~4分,于用药前及用药后1、6、12、24 h检血气分析,记录动脉血氧分压、血氧饱和度及呼吸频率,并对比上述指标的改变。结果所有患者接受镇静治疗30 min之内Ramsay评分均在2~4分,且所有患者均能被定时唤醒。使用右美托咪定后6、12、24 h患者PO2、SpO2较用药前明显升高(均P<0.05)。用药后6、12、24 h患者呼吸频率较用药前明显下降(均P<0.05)。结论右美托咪定镇静效果满意,可使患者随时保持可唤醒状态,且无呼吸抑制,安全性高,适用于神经外科颅脑外伤躁动患者的短期镇静。
出处 《中国老年学杂志》 CAS CSCD 北大核心 2011年第18期3500-3501,共2页 Chinese Journal of Gerontology
  • 相关文献

参考文献7

  • 1Mantz J. Alpha 2-adrenoceptor agonists : analgesia, sedation, anxiolysis, haemodynamics, respiratory function and weaning [ J ]. Baillieres Clin Anaesthesiol, 2000 ; 14 ( 2 ) : 443-8.
  • 2汤文喜,孙运波.右美托咪定:值得期待的重症监护病房的镇静药[J].中国新药与临床杂志,2008,27(4):296-299. 被引量:105
  • 3Nelson LE, Lu J, Guo T,et al. The alpha2-adrenoeeptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects [J]. Anesthesiology, 2003 ;98 (2) :428 -36.
  • 4易利丹,彭六保,谭重庆,崔巍,万小敏,罗霞,曹俊华,曾小慧,阳巧凤.新型镇静镇痛药——右美托咪定[J].中国新药与临床杂志,2011,30(1):5-10. 被引量:225
  • 5Cosar M, Eser O, Fidan H, et al. The neuroprotective effect of dexmedetomidine in the hippocampus of rabbits after subarachnoid hemorrhage[J]. Surg Neurol, 2009;71(1) : 54-9.
  • 6Engelhard K, Werner C, Kaspar S, et al. Effect of the alpha2-agonist dexmedetomidine on cerebral neuretransmitter concentrations during cerebral ischemia in rats[J].Anesthesiology, 2002 ;96 (2) :450-7.
  • 7Prielipp RC, Wall MH, Tobin JR,et al. Dexmedetomidine-induced sedation in volunteers decreases regional and global cerebral blood flow[ J]. Anesth Analg, 2002 ;95 (4) : 1052-9.

二级参考文献58

  • 1重症加强治疗病房病人镇痛和镇静治疗指南(2006)[J].中国实用外科杂志,2006,26(12):893-901. 被引量:221
  • 2MANTZ J. Alpharadrenoceptor agonists: analgesia, sedation, anxiolysis, haemodynamics, respiratory function and weaning [J]. Bailliere's Clin Anaesthesiol, 2000, 14(2): 443-448.
  • 3ANTTILA M, PENTTILA J, HELMINEN A, et al. Bioavailability of dexmedetomidine after extravascular doses in healthy subjects [J]. Br J Clin Pharmacol, 2003, 56(6) : 691-693.
  • 4KAROL MD, MAZE M. Pharmacokinetics and interaction pharmacodynamics of dexmedetomldine in humans [J]. Bailliere's Clin Anaesthesiol, 2000, 14(2): 261-269.
  • 5KAMIBAYASHI T, MAZE M. Clinical uses of α2-adrenergic agonists[J]. Anesthesiology, 2000, 93(5) : 1345-1349.
  • 6LAKHLANI PP, MacMILLAN LB, GUO TZ, et al. Substitution of a mutant alpha2a-adrenerglc receptor via "hit and run" gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo[J]. Proc Natl Acad Sci USA, 1997, 94(18): 9950-9955.
  • 7MAKARITSIS KP, JOHNS C, GAVRAS I, et al. Role of alpha (2)-adrenergic receptor subtypes in the acute hypertensive response to hypertonic saline infusion in anephric mice [J]. Hypertension, 2000, 35(2): 609-613.
  • 8SALLINEN J, HAAPALINNA A, VIITAMAA T, et al. Adrenergic alpha2C-receptors modulate the acoustic startle reflex, prepulse inhibition, and aggression in mlce[J]. J Neurosci, 1998, 18(8) : 3035-3042.
  • 9AANTAA R, JAAKOLA ML, KALLIO A, et al. Reduction of the minimum alveolar concentration of isoflurane by dexmedetomidine[J]. Anesthesiology, 1997, 86(5) : 1055-1060.
  • 10AANTAA R, JAAKOLA ML, KALLIO A, et al. A comparison of dexmedetomidine, and alpha 2-adrenoceptor agonist, and midazolam as i.m premedication for minor gynaecological surgery [J]. Br J Anaesth, 1991, 67(4) : 402-409.

共引文献319

同被引文献145

  • 1蔡伟萍,黄叶莉.癌症疼痛护理的研究进展[J].护理管理杂志,2005,5(6):11-13. 被引量:69
  • 2郭祚国,韦世阳,周连银,吴广球,梁振忠,袁东彬,黎岳强.脑损伤患者躁动的原因及镇静镇痛研究[J].中华创伤杂志,2005,21(10):757-760. 被引量:22
  • 3重症加强治疗病房病人镇痛和镇静治疗指南(2006)[J].中国实用外科杂志,2006,26(12):893-901. 被引量:221
  • 4张庆荣,周建新.神经外科加强监护病房镇静剂的应用[J].中国微侵袭神经外科杂志,2006,11(12):573-575. 被引量:11
  • 5赵雅度.脑出血性疾病的外科处理.见:王忠诚,主编.王忠诚神经外科学.武汉:湖北科学技术出版社,2005,864-869.
  • 6Maldon&do MD, Murillo-O&bez&s F,Terron MP,eL &l.The poLenLi&l of melatonin in reducing morbidity mort&lfty after cr&niocerebral trauma[J]. Journal of pineal research,2007,42(1):1-11.
  • 7Sharma S, de Mestral C, Hsiao M. Benchmarking trauma center perform- mice in traumatic brain injury:the limitations of mortality outcomes [ J]. J Trauma Acute Care Surg,2013 ,74(3) :890-4.
  • 8Madden C J, Tupone D, Cano G. 0.2 Adrenergic receptor-mediated inhibi- tion of thermogenesis [ J ]. J Neurosci ,2013 ,33 ( 5 ) : 2017 -28.
  • 9James ML, Olson DM, Graffagnino C. A pilot study of cerebral and hae- modynamic physiological changes during sedation with dexmedetomidine or propofol in patients with acute brain injury [ J . Anaesth Intensive Care,2012 ,40(6) :949-57.
  • 10Benggon M, Chen H, Applegate R. Effect of dexraedetomidine on brain e- dema and neurological outcomes in surgical brain injury in rats [J]. Anesth Analg,2012 , 1 15 ( 1 ) : 154-9.

引证文献18

二级引证文献167

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部